← back to search

Achim Breiling

DKFZ-ZMBH Alliance · DE
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Epigenetics and DNA Methylation, RNA modifications and cancer, Genomics and Chromatin Dynamics, and Cancer-related gene regulation.
h-index
21
citations
3,406
works
60
NIH funding
primary concept
email

Recent publications

DNA (de)methylation in embryonic stem cells controls CTCF-dependent chromatin boundaries
Genome Research 2019cited by 109position: middledoi
Rbpj expression in regulatory T cells is critical for restraining TH2 responses
Nature Communications 2019cited by 62position: middledoi
Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues
Nature Immunology 2017cited by 288position: middledoi
Measurement of Cellular Behavior by Electrochemical Impedance Sensing
Methods in molecular biology 2017cited by 4position: middledoi
Transcriptional programs that control expression of the autoimmune regulator gene Aire
Nature Immunology 2016cited by 61position: middledoi
Chromatin Immunoprecipitation
Methods in molecular biology 2016cited by 20position: lastdoi
Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond
Epigenetics & Chromatin 2015cited by 363position: firstdoi
Chronic Inflammation Induces a Novel Epigenetic Program That Is Conserved in Intestinal Adenomas and in Colorectal Cancer
Cancer Research 2015cited by 103position: middledoi
Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation
Molecular and Cellular Biology 2015cited by 59position: lastdoi
Loss of Tet Enzymes Compromises Proper Differentiation of Embryonic Stem Cells
Developmental Cell 2014cited by 344position: middledoi
Epigenetic Regulation of Pluripotency by Polycomb Group Proteins
Epigenetics and human health 2014cited by 2position: firstdoi
Loss of Tet Enzymes Compromises Proper Differentiation of Embryonic Stem Cells
DSpace@MIT (Massachusetts Institute of Technology) 2014cited by 2position: middle
Combined Deficiency of Tet1 and Tet2 Causes Epigenetic Abnormalities but Is Compatible with Postnatal Development
Developmental Cell 2013cited by 436position: middledoi
Embryonic Carcinoma Cells Show Specific Dielectric Resistance Profiles during Induced Differentiation
PLoS ONE 2013cited by 14position: lastdoi
RNA-Interference Components Are Dispensable for Transcriptional Silencing of the Drosophila Bithorax-Complex
PLoS ONE 2013cited by 8position: middledoi
Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster
Nature Communications 2012cited by 72position: lastdoi
MYC-Induced Epigenetic Activation of GATA4 in Lung Adenocarcinoma
Molecular Cancer Research 2012cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Frank Lyko · German Cancer Research Center10 papers (2012–2019)Günter Raddatz · German Cancer Research Center7 papers (2012–2019)Meelad M. Dawlaty · Massachusetts Institute of Technology4 papers (2013–2015)Rudolf Jaenisch · Massachusetts Institute of Technology4 papers (2013–2015)M. Inmaculada Barrasa · Massachusetts Institute of Technology3 papers (2013–2014)Markus Feuerer · Leibniz Association3 papers (2016–2019)Laura Wiehle · oncgnostics (Germany)3 papers (2015–2019) · 3 papers (2013–2014)Qing Gao · Jiangsu University3 papers (2013–2014)Michael Delacher · Johannes Gutenberg University Mainz3 papers (2016–2019)Albert W. Cheng · Massachusetts Institute of Technology3 papers (2013–2014)Kym F. Faull · University of California, Los Angeles3 papers (2013–2014)Thuc T. Le · Roseman University of Health Sciences3 papers (2013–2014)Tanja Musch · DKFZ-ZMBH Alliance3 papers (2012–2015)Agnes Hotz-Wagenblatt · Heidelberg University2 papers (2017–2019)Dieter Weichenhan · German Cancer Research Center2 papers (2017–2019)Jakub Abramson · Rockefeller University2 papers (2016–2019)Danny Kägebein · Ferring Pharmaceuticals (Germany)2 papers (2017–2019)Charles D. Imbusch · DKFZ-ZMBH Alliance2 papers (2017–2019)Simin Öz · German Cancer Research Center2 papers (2013–2017)